The MASCC/ISOO Annual Meeting is the leading international, multidisciplinary conference focused on supportive care in cancer.

At this year’s conference, my abstract was selected for an oral presentation that generated strong engagement from attendees, prompting numerous questions and sparking discussions about potential future collaborations.

I was grateful for the opportunity to present my poster about characterising the clinical and neurophysiological features of bortezomib-induced peripheral neuropathy.

Attending ISPNO 2026 provided an excellent opportunity to learn about recent advances in paediatric neuro-oncology, particularly in relation to high-risk brain tumours.

The main theme of EACR 2026 was innovative cancer science, focusing on advancing basic, preclinical and translational cancer research by connecting cancer research communities together.

The Cold Spring Harbor Symposium on Quantitative Biology is one of the most historically significant meetings in the life sciences. This year, the 90th Symposium was themed “AI in Biology.”

ASCO is the world’s largest clinical cancer conference, bringing together more than 40,000 clinicians, researchers and industry partners to showcase the latest advances in cancer research and their translation into patient care.

The ISCT Annual Meeting is the largest global cell and gene therapy conference, convening over 3,000 delegates from research, industry and clinical settings.

The IARC@60 Conference, celebrating the 60th anniversary of the International Agency for Research on Cancer. The conference attracted over 1,000 delegates, including researchers, clinicians, policymakers, and advocates, all united under the theme “Cancer Research into Action.”

ISMRM Annual Meeting and Exhibition is the largest conference on MRI in the world. A major theme of this year’s meeting was bringing MRI to low and middle-income countries through technologies such as portable ultra-low-field MRI.

In my Invited Keynote presentation I showcased our ongoing MERRIER online delivered exercise trial, which received a lot of interest due to our creative digital ways of getting young survivors active through play.

The theme of this year’s meeting of the Australia New Zealand Gynaecological Oncology Group was “On the Edge: Translating Innovation into Action”, and brought together clinicians, researchers, allied health professionals, trial coordinators, and consumer representatives working across gynaecological cancers.

My poster highlighted improvements in the consistency, documentation, and delivery of smoking cessation care across participating maternity services, along with a positive trend in quitting among pregnant women.

Several hundred people attended the BreastScreen Australia conference including site staff (radiographers, breast physicians, radiologists), researchers, and policy makers.

The Lorne Cancer Conference was an exceptionally valuable experience and represents a significant milestone in my professional development to date.

Lorne Cancer 2026 was attended by approximately 300 researchers, with a range of international and interstate speakers presenting exciting and innovative research.

Featuring plenary lectures, symposia, and networking events, the conference focused on “Epidemiology and Global Issues: Addressing Diversity, Complexity, and Inclusion,” exploring responses to infectious diseases, climate change, health inequities, methodological advances, and interdisciplinary research.

ASI is Australia’s peak national conference for immunology and brings together a diverse group of attendees, including basic researchers, clinician-scientists, healthcare professionals and early- to midcareer researchers

Ahead of CTOS 2025, more than 70 international experts and patient advocates came together to discuss genetic predispositions in sarcoma — an area where up to 20% of cases may be linked to inherited factors, yet clear clinical guidance remains limited.

The main theme of this congress was optimising cancer patients before surgery through multimodal prehabilitation, including exercise, nutrition, and psychological support.

The Australian Bioinformatics and Computational Biology Society (ABACBS) Conference is Australia’s largest annual meeting for bioinformatics and computational biology.

I was invited as a speaker at the Presidential Plenary of IPOS Congress 2025, my presentation titled ‘Using implementation science, choosing implementation strategies, and measuring success in psycho-oncology.

I attended a pre‑conference workshop focused on designing implementation strategies to embed exercise into routine cancer care. What made this workshop particularly valuable was the way it brought together clinicians, academics, allied health professionals, and implementation scientists from across Australia.

A personal highlight for me were presentations around equity in cancer care, focused on groups requiring specific focus in health service research including Indigenous Australians, gender diverse populations, and those affected by rare cancers in rural and regional areas.

The theme of this conference “Optimising care, optimising outcomes – Partnering to improve outcomes for all,” emphasised equity, collaboration and practical translation into clinical care.

The COSA-IPOS conference was a fantastic opportunity to get together with colleagues to discuss latest findings and chat about ways to improve cancer care.

In November I attended the 2025 COSA-IPOS joint conference, presenting as part of a symposium titled ‘Driving better outcomes: integrating cancer carer needs into healthcare reform.’

The 2025 theme of the COSA/IPOS joint congress was “Optimising care, optimising outcomes: Partnering to improve outcomes for all, was evident throughout, with a rich mix of scientific, clinical, and multidisciplinary sessions.

I recently attended the COSA–IPOS 2025 Annual Scientific Meeting, a joint conference that brought together over 1,200 delegates, including researchers, clinicians, allied health professionals, policy leaders and students.

The theme of IPVS 2025 was “Research toward the global elimination of HPV-related diseases and cancers”.

The 22nd SMR conference was a fantastic opportunity to gain knowledge and insight into all of the current research in the melanoma field and meet international colleagues and collaborators.

The SMR International Congress is the most attended melanoma conference worldwide, attracting leading experts who advance melanoma research and treatment.

I was extremely fortunate to receive the Sydney Cancer Partners conference travel award to support my attending the Society of Melanoma Research Congress in Amsterdam.

IUPESM brought together engineers and physicists working in hospitals, research institutes, or the biomedical industry. The invited speakers were leading medical physicists and engineers who shared practical examples of how their work has improved clinical practice and patient care.

The combined FAC and IMPAHC events were an excellent opportunity for continuing education in the rapidly evolving field of cancer genetics.

IMPAHC brought together researchers, clinicians, and advocates to explore the evolving landscape of hereditary and genomic cancer care, with a strong emphasis on psychosocial experiences and patient-centred approaches.

The 67th Annual Meeting & Exhibition of the American Association of Physicists in Medicine (AAPM) took place from July 27–30, 2025, at the Walter E. Washington Convention Center in Washington, DC.

The theme for 2025 AAPM was “Coming Together to Forge Ahead in Medical Physics”, fostering collaboration across disciplines and showcasing advancements in therapy, diagnostics, radiopharmaceuticals, AI, and professional development and I presented a poster titled “Predicting Prostate Cancer Recurrence Using an Atlas-Based Tumor Control Probability Model”.

The AAPM annual meeting is one of the largest medical physics conferences in the world, with around 4,000 medical physics professionals in attendance, from over 85 countries. There were over 2,000 abstracts and 300 invited speakers, covering groundbreaking data science innovations to the latest strides in imaging and therapy.

Feeling truly grateful to deliver a keynote talk at the Asia Pacific Society for Extracellular Vesicles Conference (APSEV). It was a meaningful opportunity to reflect on the remarkable progress in the EV field and my own 16+ years journey with extracellular vesicles.

The Multinational Association of Supportive Care in Cancer meeting is one that is very pertinent to my research area, so being able to present my research at this meeting, participate in a panel discussion and chair a session is a very proud achievement.

I was lucky enough to be invited to present an oral and be accepted for two posters at The 11th International Breast Density & Cancer Risk Assessment Workshop in Lihue, Hawaii in June 2025. This biennial, internationally renowned workshop brought together over 120 leading experts in breast cancer.

The European Association of Palliative Care’s (EAPC) World Congress attracts more than 1000 delegates from all over the world. I attended this year to present results from a systematic review on breathlessness interventions for people with lung cancer.

The AACR Annual Meeting, with over 20,000 delegates from around the globe, highlighted cutting-edge advances across all aspects of cancer biology and translational research.

The program for the 14th General Breast Imaging Meeting 2025 included multidisciplinary speakers and delegates from diverse fields, such as radiology, breast imaging, cancer screening, and artificial intelligence.

This conference focusses on medical genetics and is regarded as one of the most prominent events in the field, attracting leading experts from around the world.

The Cancer Survivorship Conference is one of my favourite conferences, as it is always well attended by a diverse group of researchers, clinicians, and consumers across Australia and generates really interesting discussions.

The theme for this conference was “Building Capability and Capacity in Survivorship Care and Research” to highlight the importance of improving survivorship care from individuals to the health system level. This was a fantastic opportunity to learn from national leaders in cancer survivorship care.

The PHAA Screening Conference this year focused on new and emerging opportunities for screening with presentations on exciting fields like genomic testing and multi-cancer assays, which are reaching the potential for population rollout.

This prestigious event brought together over 1,000 delegates across the world, including researchers, clinicians, and experts from a range of fields such as radiology, image processing, computer-aided diagnosis, and medical imaging technologies.

I was invited to give a keynote presentation at the 14th International Head and Neck Quality of Life Conference in Leeds, UK. The conference brings together a mixture of clinicians, including oncologists, surgeons, allied health practitioners and nurses with researchers who all have an interest in QoL for people with head and neck cancer.

The theme for this year was “Bridging gaps, building progress, breaking down disparities”. The equity focus relates directly to my PhD which aims to reduce age related disparities in cancer care.

This was the first time I have attended this largest national gathering of experts in clinical oncology research. Being an early career researcher in this field, it was highly important that I was able to share my research, as well as learn from experts in the field.

The beautiful Gold Coast was the perfect location for over 1000 cancer clinicians from all disciplines to gather around the theme: Bridging gaps, building progress, breaking down disparities. There was a palpable eagerness to address global and local issues in accessing healthcare, highlighted beautifully by keynote speakers Dr. Danielle Rodin (Princess Margaret Cancer Centre, Canada) and Dr. Robin Zon (ASCO President, USA) from the very first plenary session.

EPSM is the largest medical physics conference in Australia and brings together researchers and clinical professionals, making it one of the best forums for researchers and clinical staff to connect and form new collaborations.

COSA is a multidisciplinary meeting, serving as a platform for health professionals and researchers working in cancer care nationally and internationally to showcase current, high-quality research. The theme for COSA 2024 was Bridging gaps, building progress, breaking down disparities.

The Frontiers in Cancer Science 2024 conference in Singapore is one of the premier cancer conferences organised in the Asia Pacific region. One of the key areas where the conference ended up converging was on different cancer immunotherapies and immunomodulatory approaches.

Over 1,800 delegates from many different countries attended this conference including clinicians, clinical researchers, translational medical researchers, medical students & healthcare providers.

The ESMO Congress of 2024 was held in Barcelona, Spain, attended by 34,000 participants from 149 countries. At times I found myself making difficult decisions between which practice changing presentations to attend.

The IPOS 2024 World Congress is a premier international gathering focused on integrating psychosocial care into comprehensive cancer treatment. This year’s theme “Cancer in Context” highlighted the need to consider personal and social factors affecting the cancer experience.

The International Clinical Trial Methodology Conference offers a unique platform focused on the conduct of clinical trials, rather than their outcomes. This approach is invaluable for professionals who work in trial methodology to enhance efficiency in trial operations.

The International Clinical Trials Methodology Conference attracted a multi-disciplinary audience of over 1,000 participants engaged across the spectrum of clinical trials and showcased the latest research in the ‘science of’ clinical trial design and methodology.

Almost 2000 participants from over 120 countries attended the 2024 World Cancer Congress in Geneva. The congress was built around the themes including equity, patient perspective, leadership and sustainable impact, and emphasised innovation, collaboration, and policy development to reduce cancer’s global burden.

The theme of this year’s AAPM meeting was “Embracing Change, Impacting Patient Care”. This theme was reflected throughout in the talks on emerging technologies, patient impact and outcomes from clinical trials globally, focussed sessions and meetings on disseminating current practices at various clinics and developing guidelines for clinical procedures and practices.

The AAPM Meeting showcases some of the leading work on medical physics for cancer treatment, with a focus on translational cancer research, research translation and evidence-based clinical practice. AAPM task groups routinely determine clinical guidelines for radiation therapy practice that are subsequently adopted around the world.

The annual MASCC conference is a leading event in the field of supportive cancer care. The theme for the MASCC/AFSOS/ISOO 2024 was “Empowering People Impacted by Cancer and Living with Toxicities”.

The ESMO Gynaecological Cancers Congress 2024 focused on advancing knowledge and collaboration in the field of gynaecological oncology around the theme of recent advancements in diagnosis, treatment modalities, and patient care strategies.

In the Digital and Quantitative Pathology Companion Club session, I was invited to present a synopsis of the current RCPA Draft Guidance Document for Artificial Intelligence in Pathology, a document intended to help pathologists, laboratories, and ultimately regulatory authorities safely implement AI-related tools in pathology practice.

The American College of Sports Medicine Annual Scientific Meeting, the largest exercise medicine conference globally, began with an Exercise Oncology preconference meeting aimed at establishing a new society called the International Society of Exercise Oncology.

This meeting boasted a global audience of over 1000 researchers specialising in extracellular vesicles. The theme of the meeting was “Discover, Innovate and Understand”. Attendees had diverse interests spanning bacterial and plant biology, cancer biomarkers, cancer metastasis, therapeutics and nanotechnology.

The ISMRM Annual Meeting is the largest event of its kind, dedicated to advancements in MRI technology. This year, the conference attracted over 5000 delegates from around the globe, including researchers, clinicians, and industry professionals. The central theme revolved around developing and integrating cutting-edge MRI technology into medical research and clinical practice.

I had the privilege of attending the Cancer & Primary Care Research Network (Ca-PRI) conference in Melbourne. It marked the first Ca-PRI conference in the southern hemisphere with over 200 delegates from researchers, policymakers, and clinicians representing 60 countries in attendance.

BreastScreen Australia Conference provided a highly valuable opportunity to attend my first conference as a PhD candidate and to present a systematic review on clinical guidelines for the management of women with dense breasts around the world.

This conference has sparked new research ideas for me particularly looking at programs in our local hospitals comparing clinician and patient perceptions to see if we can improve the quality of care for our patients.

Aus MRinRT is all about the use of MRI and radiotherapy for treatment of cancers and covers a wide range of topics from fundamental physics, cancer biology and clinical research.

I had the pleasure of attending the ASBHM Annual Scientific Conference on Kaurna country in Adelaide. This conference has a strong focus on theory-driven models for behaviour change in designing translational research, as well as critique of these models in delivering healthcare.

ICMP was attended by over 1000 delegates including medical physicists, radiation oncologists and researchers from all over the world. The theme was Innovations in Radiation Technology and Medical Physics for Better Healthcare, particularly focussing on automation in radiation therapy.

The San Antonio Breast Cancer Symposium typically attracts close to 10,000 attendees from 100 countries and is the premier international platform for breast cancer research.

With the support of a Sydney Cancer Partners Conference Support Grant, I was able to attend two key oncology meetings of crucial relevance to my work. The first conference I attended was the PoCoG ASM, which was a one-day conference dedicated to psycho-oncology research and practice.

The theme this year was 50 years of innovation in cancer care: Learning from the past to inspire the future. COSA features a multi-disciplinary membership, conference delegates included clinicians and researchers working in various areas which was reflected in the breadth of presentation topics covered across the course of the conference.

I was very excited to attend the COSA Annual Scientific Meeting in person this year particularly as this was my first in-person conference.

This conference, with >1000 delegates was the 50th anniversary of the organisation. It was highlighted by amazing presenters such as Prof Michael Friedlander giving an overview of how ovarian cancer treatment has changed since he started working in the late 1970s.

This annual meeting of the Royal Australian College of Radiologists (encompassing both Clinical Radiology and Radiation Oncology) was attended by over 1500 delegates. The theme of this year’s ASM was “Beyond”.

The European Association in Neuro-Oncology (EANO) Annual Meeting is the second largest neuro-oncology conference in the world.

The 2023 World Congress of Psycho-Oncology was the 24th annual conference under the auspices of the International Psycho-Oncology Society (IPOS). This conference has a focus on both translational cancer research and evidence based clinical practice in psycho-oncology.

The Australian and New Zealand Head and Neck Cancer Society Annual Scientific Meeting is the premier head and neck cancer meeting in Australia. It was the first time that this Scientific Meeting was held in a regional area as well as having a convenor who was an allied health professional, a physiotherapist.

I was recently very fortunate to attend and present my research at the third AACR-AHNS conference where leaders in the field presented their latest research and critical updates on head and neck cancer biology, detection, imaging, prevention, and therapies.

The American Association of Physicists in Medicine (AAPM) annual meeting is the largest and most prestigious conference in the field of medical physics, attended by over 4,000 international experts.

I was very lucky to be supported by Sydney Cancer Partners to attend two back-to-back international conferences in June, firstly in Copenhagen Denmark, followed by Nara Japan.

The Multinational Association of Supportive Care in Cancer (MASCC) is an international, interdisciplinary organisation dedicated to the practice, education, and research of supportive care in cancer.

The ISMRM & ISMRT Annual Meeting is the largest meeting of MRI professionals across the world, with more than 5000 attendees in 2023, including MRI radiologists, radiographers and physicists.

In April 2023 I attended the 35^th International Papillomavirus Conference (IPVC 2023) in Washington DC, along with almost 1800 others working in the field, from over 100 countries.

I attended the AACR Annual Meeting in Orlando Florida from the 16 -19 April, where I gave a presentation on our study on longitudinal microbiome-immune dynamics during immune checkpoint inhibitor immunotherapy.

The AACR annual meeting brings together cancer researchers, both clinicians and basic scientists of all levels and fields to present and discuss the latest in cancer research.  It is the largest cancer conference in the world and this year there were approximately 21,000 attendees.

CBCC2023 was an amazing opportunity. I got to share my research, and hear from and meet some great researchers in my field. I am very grateful for the travel grant from Sydney Cancer Partners and Cancer Institute NSW that supported me to attend this wonderful conference.

The Australasian Melanoma Conference was attended by approximately 350 clinicians, researchers and consumers, over two typically hot and humid Brisbane days. There were two plenary sessions and six concurrent sessions (20 sessions in total) covering epidemiology, clinical practice, pathology, basic science, and emerging treatments and technologies to detect and treat melanoma, and the lived experiences of skin cancer from inspiring consumers and advocates.

It was a great experience to participate in the 6^th COSA Cancer Survivorship 2023 which was held on 9-10 March at the Adelaide Convention Centre. The conference theme for this year is ‘Solidarity in Survivorship: bringing us together’.

The Australian Lung Cancer Conference (ALCC) was held in mid-February in the Gold Coast Queensland This is a multidisciplinary conference with oncologists, scientists, nursing staff, radiation oncologists and respiratory physicians to come together to discuss emerging research in lung cancer.

The HUPO Annual Congress is a unique international event that provides a platform for translational and clinical proteomic scientists to learn about advancements in clinical proteomics, share their works and discuss future collaborations. Proteomic is defined as large-scale studies of proteins in cells and tissues. The HUPO congress offers multiple pre- and post-congress workshops and commercialization courses as well as ECR mentoring events that are filled with up-to-date training opportunities on emerging proteomic data analysis, data interpretation, and translation.

ASI2022 was a fantastic meeting of immunologist in Australian and New Zealand and was my first big
conference or meeting in my PhD. It was attended by over 1000 delegates, audience was
immunologist researchers with some clinicians. As well as many incredibly impressive invited
speakers. I got to connect with old colleagues, meet exciting people in the field and ask interesting
questions.

The Clinical Oncology Society of Australia (COSA) Annual Scientific Meeting brought together some 600 clinicians, researchers, and communities in the cancer space to discuss the latest research and programs of work that endeavour to make a difference in the lives of people affected by cancer.

I was exceedingly grateful to have this opportunity to attend the American Society of Dermatopathology 59th annual meeting. This is a leading large conference in this field, attracting a diverse range of well-known USA speakers covering a breadth of topics related to dermatopathology (including nail disorders, artificial intelligence, skin lymphomas, molecular advances, melanoma-related pathology, and legal aspects to care).

The International Clinical Trial Methodology Conference is a focussed arena for dissemination of trials methodology research. Over 800 delegates from more than 22 countries attended the 2022 conference. As a trial methodologist, this conference is of singular importance for networking and learning.

The EMBO telomere conference is one of two major international telomere meetings that are held in alternative years. This meeting attracts all the major research groups in the telomere field and showcases the top telomere and associated research developments. Specifically, it covers the topics of telomere structure/function, telomere protection/replication and telomere maintenance mechanisms, telomere transcription and telomere biology disorders (genetic and in cancer).

Thanks to funding from Sydney Cancer Partners, I attended the International Conference on Communication in Healthcare in September at Glasgow Caledonian University. It was great to both be able to attend alongside my colleagues from the Sydney Health Literacy Lab (Prof Kirsten McCaffery, Dr Tessa Copp, Dr Julie Ayre & Olivia Mac) and also meet many health communication researchers, clinicians and teachers I otherwise would not have been able to meet. I am very grateful for the funding from Sydney Cancer Partners!

The 11th ANZUP ASM brought together 400 multi-disciplinary delegates working in genitourinary (GU) cancer, including doctors, nurses, allied health, researchers and consumers. The ASM presents the latest updates in research, diagnosis, treatment and management of GU cancers and is the key Australian conference for discussion and dissemination of ANZUP-led clinical trials and other GU-focused trials.

The annual meeting of the American Association of Physicists in Medicine (AAPM) is the largest and most prestigious annual global conference in the field of medical physics, with around 4,000 international attendees over 5 days. However, since moving into my current research group 3 years ago, the AAPM annual conference has been held online, like the majority of conferences during the COVID era. While I have been very grateful to attend, be able to present my research and listen to others, virtual attendance is just unable to offer the full experience.